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Druggable targets for 
Robinow Syndrome 
Motivation
• Robinow Syndrome is a rare genetic syndrome. 
The diagnostic features of Robinow Syndrome 
include shorter stature, a wider face and a 
prominent forehead. 
• Some patients experience bone overgrowth that 
impinges on nerves and causes pain. 
• The only treatment is neurosurgery to remove the 
bony overgrowths.
Project Description
• Using a mouse model (Prickle1Beetlejuice) and 
patient cells we will determine if FDA-approved 
drugs can modify the disease. 
Potential Impact
• We hope to prevent the need for repeated 
neurosurgeries for patients with Robinow 
Syndrome.
• If the FDA-approved drugs modify the patient 
disease, then we will have identified a 
pharmaceutical treatment that can modify 
Robinow Syndrome.
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Context 
• The only treatment option to relieve pain for 
these patients is surgically excise the bone 
overgrowth. 
• Often the patients require several surgeries.
• Our analysis of the mouse model suggests that 
two pathways have altered signaling in bone 
cells. These pathways have FDA-approved drugs 
to modulate them.
• By identifying and testing FDA-approved drugs in 
our in vivo and in vitro model systems we 
hypothesize that we will be able to halt bone 
growth. 
Project Deliverables
• Invention Disclosure filed with the Innovation 
Institute by 6 months.
• This project will provide the data for a competitive 
R01 application prior to the end of the funding 
period.
• Within 1-2 years, we expect to have submitted a 
high-impact paper with our results.
